SULPERAZON Side Effects

7022471-7 | Platelet Count Decreased
on Sep 20, 2010 Male patient from CHINA , 82 years of age, was diagnosed with lung infection and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Sulperazon dosage: 3g, 3x/day.

7017465-1 | Epilepsy
Patient was taking Sulperazon (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?) on Sep 16, 2010 from CHINA Additional patient health information: Male patient , 27 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Sulperazon dosage: 3 G, 2x/day.

6984600-0 | Epilepsy
Adverse event was reported on Sep 03, 2010 by a Male patient taking Sulperazon (View Usage) (Dosage: 3 G, 2x/day) was diagnosed with pneumonia (What is pneumonia?) and. Location: CHINA , 27 years of age, After Sulperazon was administered, patient had the following side effects: epilepsy (What is epilepsy?).

6978374-7 | Apnoea, Dyspnoea
on Sep 02, 2010 Male patient from POLAND , 74 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: apnoea, dyspnoea. Sulperazon dosage: Unk.


6973381-2 | Dyspepsia, Dyspnoea, Gastrooesophageal Reflux Disease, Hyperhidrosis
on Aug 31, 2010 Female patient from PHILIPPINES , 27 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Sulperazon (View Usage). Patient had the following side effects: dyspepsia, dyspnoea, gastrooesophageal reflux disease, hyperhidrosis. Sulperazon dosage: . During the same period patient was treated with OFLOXACIN (Unk) (View Ofloxacin Review and Ofloxacin Label ).

6970923-8 | White Blood Cell Count Decreased
Patient was taking Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: white blood cell count decreased on Aug 30, 2010 from JAPAN Additional patient health information: Male patient , 71 years of age, . Sulperazon dosage: Unk.

6958171-9 | White Blood Cell Count Decreased
Adverse event was reported on Aug 19, 2010 by a Male patient taking Sulperazon (View Usage) (Dosage: Unk) . Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: white blood cell count decreased.

6929989-3 | White Blood Cell Count Decreased
on Aug 09, 2010 Male patient from JAPAN , 71 years of age, was treated with Sulperazon (View Usage). Patient had the following side effects: white blood cell count decreased. Sulperazon dosage: Unk.

6916299-3 | Haemorrhagic Diathesis, Lividity
on Jul 30, 2010 Female patient from CHINA , 30 years of age, was diagnosed with inflammation and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: haemorrhagic diathesis, lividity. Sulperazon dosage: 3 G, 2x/day.

6895395-3 | Alcohol Interaction, Asthenia, Flushing, Hyperhidrosis, Syncope
Patient was taking Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol interaction, asthenia, flushing, hyperhidrosis, syncope on Jul 22, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with infection (What is infection?), hypertension, cerebral infarction, hyperuricaemia, hyperlipidaemia and. Sulperazon dosage: 1 G, 2x/day. During the same period patient was treated with MINIPRESS (Unk) (View Minipress Review and Minipress Label ), NU LOTAN (Unk) (View Nu Lotan Review and Nu Lotan Label ), PERSANTINE (150 Mg, 2x/day) (View Persantine Review and Persantine Label ), HARNAL (0.2 Mg, 1x/day) (View Harnal Review and Harnal Label ), PANALDINE (Unk) (View Panaldine Review and Panaldine Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), BEZATOL (Unk) (View Bezatol Review and Bezatol Label ), FLUITRAN (Unk) (View Fluitran Review and Fluitran Label ).

6840345-9 | Asthenia, Flushing, Hyperhidrosis, Syncope
Adverse event was reported on Jul 05, 2010 by a Male patient taking Sulperazon (View Usage) (Dosage: 1 G, 2x/day) was diagnosed with infection (What is infection?), hypertension, cerebral infarction, hyperuricaemia, hyperlipidaemia and. Location: JAPAN , 77 years of age, Patient had the following side effects: asthenia, flushing, hyperhidrosis, syncope. During the same period patient was treated with AMLODIN (Unk) (View Amlodin Review and Amlodin Label ), MINIPRESS (Unk) (View Minipress Review and Minipress Label ), NU LOTAN (Unk) (View Nu Lotan Review and Nu Lotan Label ), PANALDINE (Unk) (View Panaldine Review and Panaldine Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), BEZATOL (Unk) (View Bezatol Review and Bezatol Label ), PERSANTINE (View Persantine Review and Persantine Label ), HARNAL (View Harnal Review and Harnal Label ).

6835670-1 | Anaphylactic Shock
on Jul 05, 2010 Male patient from JAPAN , 67 years of age, weighting 131.4 lb, was diagnosed with cholangitis and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: anaphylactic shock. Sulperazon dosage: 1 G, 1x/day.

6819386-3 | Platelet Count Decreased
on Jun 28, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with pleurisy and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Sulperazon dosage: Unk. During the same period patient was treated with NAUZELIN (Unk) (View Nauzelin Review and Nauzelin Label ), BIO THREE (View Bio Three Review and Bio Three Label ), MAGNESIUM OXIDE HEAVY (Unk) (View Magnesium Oxide Heavy Review and Magnesium Oxide Heavy Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), SOLDOL E (View Soldol E Review and Soldol E Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), LASIX (View Lasix Review and Lasix Label ), PENTCILLIN (Unk) (View Pentcillin Review and Pentcillin Label ).

6817715-8 | Anaphylactic Shock
Patient was taking Sulperazon (View Usage). Patient had the following side effects: anaphylactic shock on Jun 25, 2010 from JAPAN Additional patient health information: Male patient , 67 years of age, weighting 131.4 lb, was diagnosed with cholangitis and. Sulperazon dosage: 1 G, 1x/day.

6812566-2 | Dermatitis Exfoliative, Hepatic Lesion
Adverse event was reported on Jun 21, 2010 by a Female patient taking Sulperazon (View Usage) (Dosage: 1.5 G, 3x/day) was diagnosed with infection (What is infection?) and. Location: CHINA , 46 years of age, After Sulperazon was administered, patient had the following side effects: dermatitis exfoliative, hepatic lesion. During the same period patient was treated with PIPERACILLIN SODIUM W/TAZOBACTAM SODIUM (4.5 G, 2x/day) (View Piperacillin Sodium W/tazobactam Sodium Review and Piperacillin Sodium W/tazobactam Sodium Label ), NORVANCOMYCIN HYDROCHLORIDE (0.4 G, 2x/day) (View Norvancomycin Hydrochloride Review and Norvancomycin Hydrochloride Label ), DIOVAN (80 Mg, 1x/day) (View Diovan Review and Diovan Label ).

6809713-5 | Loss Of Consciousness, Rash
on Jun 18, 2010 Male patient from JAPAN , 77 years of age, was diagnosed with infection (What is infection?) and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, rash (What is rash?). Sulperazon dosage: 2 G Daily. During the same period patient was treated with NU LOTAN (View Nu Lotan Review and Nu Lotan Label ), PANALDINE (View Panaldine Review and Panaldine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BEZATOL (View Bezatol Review and Bezatol Label ), PERSANTINE (View Persantine Review and Persantine Label ), HARNAL (View Harnal Review and Harnal Label ), MINIPRESS (View Minipress Review and Minipress Label ), FLUITRAN (View Fluitran Review and Fluitran Label ).

6803297-3 | Coagulation Test Abnormal
on Jun 17, 2010 Male patient from JAPAN , 88 years of age, weighting 108.0 lb, was diagnosed with pneumonia (What is pneumonia?), dementia alzheimer's type, atrial fibrillation (What is atrial fibrillation?), constipation (What is constipation?), delirium and was treated with Sulperazon (View Usage). Patient had the following side effects: coagulation test abnormal. Sulperazon dosage: 1 G, 2x/day. During the same period patient was treated with PENTCILLIN (2 G, 2x/day) (View Pentcillin Review and Pentcillin Label ), GARENOXACIN MESILATE (400 Mg, 1x/day) (View Garenoxacin Mesilate Review and Garenoxacin Mesilate Label ), CRAVIT (500 Mg, 1x/day) (View Cravit Review and Cravit Label ), ARICEPT (10 Mg, 1x/day) (View Aricept Review and Aricept Label ), SUNRYTHM (50 Mg, 3x/day) (View Sunrythm Review and Sunrythm Label ), GASMOTIN (5 Meq/l, 3x/day) (View Gasmotin Review and Gasmotin Label ), TETRAMIDE (20 Mg, 2x/day) (View Tetramide Review and Tetramide Label ). Patient was hospitalized.

6789936-4 | Anaphylactic Shock
Patient was taking Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: anaphylactic shock on Jun 14, 2010 from JAPAN Additional patient health information: Male patient , 67 years of age, weighting 131.4 lb, was diagnosed with cholangitis and. Sulperazon dosage: 1 G, 1x/day.

6783255-8 | Haemorrhagic Diathesis
Adverse event was reported on Jun 11, 2010 by a Female patient taking Sulperazon (View Usage) (Dosage: Unk) . Location: JAPAN , 73 years of age, Patient experienced the following unwanted or unexpected effects: haemorrhagic diathesis. During the same period patient was treated with WARFARIN POTASSIUM (Unk) (View Warfarin Potassium Review and Warfarin Potassium Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6779692-8 | Epistaxis
on Jun 07, 2010 Female patient from TURKEY , 54 years of age, was diagnosed with escherichia infection and was treated with Sulperazon (View Usage). Patient had the following side effects: epistaxis. Sulperazon dosage: .

6774232-1 | Disease Progression, Nervous System Disorder
on Jun 08, 2010 Male patient from TURKEY , 53 years of age, was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: disease progression, nervous system disorder. Sulperazon dosage: Unk.

6770335-6 | White Blood Cell Count Increased
Patient was taking Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count increased on Jun 04, 2010 from CHINA Additional patient health information: Female patient , 75 years of age, . Sulperazon dosage: 3 G, 2x/day. During the same period patient was treated with OMEPRAZOLE (40 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), FAT EMULSIONS (250 Ml, /24h) (View Fat Emulsions Review and Fat Emulsions Label ).

6769638-0 | Coagulation Test Abnormal
Adverse event was reported on Jun 03, 2010 by a Male patient taking Sulperazon (View Usage) (Dosage: 1 G, 2x/day) was diagnosed with pneumonia (What is pneumonia?), dementia alzheimer's type, atrial fibrillation (What is atrial fibrillation?), constipation (What is constipation?), delirium and. Location: JAPAN , 88 years of age, weighting 108.0 lb, Patient had the following side effects: coagulation test abnormal. During the same period patient was treated with PENTCILLIN (2 G, 2x/day) (View Pentcillin Review and Pentcillin Label ), GARENOXACIN MESILATE (400 Mg, 1x/day) (View Garenoxacin Mesilate Review and Garenoxacin Mesilate Label ), CRAVIT (500 Mg, 1x/day) (View Cravit Review and Cravit Label ), ARICEPT (10 Mg, 1x/day) (View Aricept Review and Aricept Label ), SUNRYTHM (50 Mg, 3x/day) (View Sunrythm Review and Sunrythm Label ), GASMOTIN (5 Meq/l, 3x/day) (View Gasmotin Review and Gasmotin Label ), TETRAMIDE (20 Mg, 2x/day) (View Tetramide Review and Tetramide Label ).

6763894-0 | Platelet Count Decreased
on Jun 01, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with pleurisy and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: platelet count decreased. Sulperazon dosage: Unk. During the same period patient was treated with NAUZELIN (Unk) (View Nauzelin Review and Nauzelin Label ), BIO THREE (View Bio Three Review and Bio Three Label ), MAGNESIUM OXIDE HEAVY (Unk) (View Magnesium Oxide Heavy Review and Magnesium Oxide Heavy Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), SOLDOL E (View Soldol E Review and Soldol E Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), LASIX (View Lasix Review and Lasix Label ), PENTCILLIN (Unk) (View Pentcillin Review and Pentcillin Label ).

6762559-9 | White Blood Cell Count Decreased
on May 28, 2010 Male patient from JAPAN , 69 years of age, was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count decreased. Sulperazon dosage: .

6759221-5 | White Blood Cell Count Increased
Patient was taking Sulperazon (View Usage). Patient had the following side effects: white blood cell count increased on May 26, 2010 from CHINA Additional patient health information: Male patient , 71 years of age, . Sulperazon dosage: 3 G, 2x/day. During the same period patient was treated with CLINDAMYCIN PHOSPHATE (0.3 G, 2x/day) (View Clindamycin Phosphate Review and Clindamycin Phosphate Label ), DEXAMETHASONE SODIUM PHOSPHATE (3 Mg, 2x/day) (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), AMINOPHYLLINE (0.25 G, 2x/day) (View Aminophylline Review and Aminophylline Label ).

6759219-7 | White Blood Cell Count Increased
Adverse event was reported on May 26, 2010 by a Female patient taking Sulperazon (View Usage) (Dosage: 3 G, 2x/day) . Location: CHINA , 75 years of age, After Sulperazon was administered, patient had the following side effects: white blood cell count increased. During the same period patient was treated with OMEPRAZOLE (40 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), FAT EMULSIONS (250 Ml, /24h) (View Fat Emulsions Review and Fat Emulsions Label ).

6750261-9 | Anaphylactic Shock
on May 21, 2010 Female patient from CHINA , 42 years of age, weighting 143.3 lb, was diagnosed with infection (What is infection?), malaria (What is malaria?) and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Sulperazon dosage: 1.0 G, 3x/day. During the same period patient was treated with NORVANCOMYCIN (400 Mg, 3x/day) (View Norvancomycin Review and Norvancomycin Label ), LEVOFLOXACIN (Unk) (View Levofloxacin Review and Levofloxacin Label ), MEROPENEM (0.5 G, 3x/day) (View Meropenem Review and Meropenem Label ), COARTEM (160 Mg, 1x/day) (View Coartem Review and Coartem Label ).

6746002-1 | Coagulation Test Abnormal
on May 19, 2010 Male patient from JAPAN , 88 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Sulperazon (View Usage). Patient had the following side effects: coagulation test abnormal. Sulperazon dosage: 2g/day. During the same period patient was treated with PENTCILLIN (View Pentcillin Review and Pentcillin Label ), GARENOXACIN MESILATE (View Garenoxacin Mesilate Review and Garenoxacin Mesilate Label ), CRAVIT (View Cravit Review and Cravit Label ).

6744380-0 | Anaphylactic Shock
Patient was taking Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: anaphylactic shock on May 18, 2010 from CHINA Additional patient health information: Female patient , 42 years of age, weighting 143.3 lb, was diagnosed with infection (What is infection?), malaria (What is malaria?) and. Sulperazon dosage: 1.0 G, 3x/day. During the same period patient was treated with NORVANCOMYCIN (400 Mg, 3x/day) (View Norvancomycin Review and Norvancomycin Label ), LEVOFLOXACIN (Unk) (View Levofloxacin Review and Levofloxacin Label ), MEROPENEM (0.5 G, 3x/day) (View Meropenem Review and Meropenem Label ), COARTEM (160 Mg, 1x/day) (View Coartem Review and Coartem Label ).

6741317-5 | Anaphylactic Shock
Adverse event was reported on May 17, 2010 by a Male patient taking Sulperazon (View Usage) (Dosage: 1 G, 1x/day) was diagnosed with infection prophylaxis, pancreatitis, cholangitis and. Location: JAPAN , 65 years of age, weighting 112.7 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic shock. During the same period patient was treated with MIRACLID (Unk) (View Miraclid Review and Miraclid Label ).

6739928-6 | Platelet Count Decreased
on May 13, 2010 Female patient from JAPAN , 76 years of age, was treated with Sulperazon (View Usage). Patient had the following side effects: platelet count decreased. Sulperazon dosage: Unk.

6731744-4 | Anaphylactic Shock, Hypoxic Encephalopathy
on May 07, 2010 Male patient from JAPAN , 80 years of age, was diagnosed with cholangitis suppurative, bile duct stone and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: anaphylactic shock, hypoxic encephalopathy. Sulperazon dosage: Unk. During the same period patient was treated with SOLULACT (500 Ml, Unk) (View Solulact Review and Solulact Label ).

6697157-9 | Blood Pressure Decreased, Loss Of Consciousness
Patient was taking Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, loss of consciousness on Apr 15, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with infection (What is infection?), pancreatitis and. Sulperazon dosage: 1 G, 2x/day. During the same period patient was treated with MIRACLID (Unk) (View Miraclid Review and Miraclid Label ).

6694466-4 | Renal Failure Acute
Adverse event was reported on Apr 13, 2010 by a Female patient taking Sulperazon (View Usage) (Dosage: 1 G, 3x/day) . Location: JAPAN , 73 years of age, Patient had the following side effects: renal failure acute.

6682343-4 | Rash
on Apr 06, 2010 Female patient from JAPAN , 86 years of age, was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: rash (What is rash?). Sulperazon dosage: 1 G, 2x/day.

6678732-4 | Renal Failure Acute
on Apr 01, 2010 Female patient from JAPAN , 73 years of age, was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Sulperazon dosage: 1 G, 3x/day.

6673433-0 | Anaphylactic Shock, Hypoxic Encephalopathy
Patient was taking Sulperazon (View Usage). Patient had the following side effects: anaphylactic shock, hypoxic encephalopathy on Mar 29, 2010 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with cholangitis suppurative and. Sulperazon dosage: Unk. During the same period patient was treated with SOLULACT (500 Ml, Unk) (View Solulact Review and Solulact Label ).

6672749-1 | Erythema
Adverse event was reported on Mar 29, 2010 by a Female patient taking Sulperazon (View Usage) (Dosage: 1 G, 2x/day) . Location: JAPAN , 86 years of age, After Sulperazon was administered, patient had the following side effects: erythema.

6634799-0 | Haemorrhagic Diathesis
on Mar 03, 2010 Female patient from JAPAN , 73 years of age, was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhagic diathesis. Sulperazon dosage: Unk. During the same period patient was treated with WARFARIN POTASSIUM (Unk) (View Warfarin Potassium Review and Warfarin Potassium Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6594178-1 | Toxic Epidermal Necrolysis
on Feb 12, 2010 Male patient from THAILAND , 50 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Sulperazon (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Sulperazon dosage: 1.5 G, 2x/day. During the same period patient was treated with METRONIDAZOLE (2 Tablets, 3 Times Daily) (View Metronidazole Review and Metronidazole Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), TIENAM (Unk) (View Tienam Review and Tienam Label ), FOSFOMYCIN (2 G, 2x/day) (View Fosfomycin Review and Fosfomycin Label ).

6519758-0 | Stevens-johnson Syndrome
Patient was taking Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: stevens-johnson syndrome on Dec 15, 2009 from THAILAND Additional patient health information: Male patient , 50 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Sulperazon dosage: 1.5 G, 2x/day. During the same period patient was treated with METRONIDAZOLE AND METRONIDAZOLE BENZOATE AND METRONIDAZOLE HYDROCHLORI (2 Tablets, 3 Times Daily) (View Metronidazole And Metronidazole Benzoate And Metronidazole Hydrochlori Review and Metronidazole And Metronidazole Benzoate And Metronidazole Hydrochlori Label ), TIENAM (Unk) (View Tienam Review and Tienam Label ), FOSFOMYCIN (2 G, 2x/day) (View Fosfomycin Review and Fosfomycin Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ).

6490547-9 | Alcohol Intolerance, Myocardial Ischaemia
Adverse event was reported on Dec 01, 2009 by a Male patient taking Sulperazon (View Usage) (Dosage: 2 G, 2x/day) . Location: CHINA , 68 years of age, Patient experienced the following unwanted or unexpected effects: alcohol intolerance, myocardial ischaemia. During the same period patient was treated with TINIDAZOLE (View Tinidazole Review and Tinidazole Label ).

6464527-3 | Dizziness, Myocardial Ischaemia
on Nov 19, 2009 Male patient from CHINA , 68 years of age, was treated with Sulperazon (View Usage). Patient had the following side effects: dizziness (What is dizziness?), myocardial ischaemia. Sulperazon dosage: .

6441734-7 | Chronic Obstructive Pulmonary Disease
on Nov 05, 2009 Male patient from CHINA , 65 years of age, was diagnosed with lung infection and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: chronic obstructive pulmonary disease. Sulperazon dosage: Unk. During the same period patient was treated with FORTUM (View Fortum Review and Fortum Label ).

6425602-2 | Platelet Count Decreased
Patient was taking Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased on Oct 22, 2009 from JAPAN Additional patient health information: Female patient , 54 years of age, . Sulperazon dosage: 1 G, 2x/day. During the same period patient was treated with ADALAT CC (Unk) (View Adalat Cc Review and Adalat Cc Label ), DILTIAZEM HYDROCHLORIDE (Unk) (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ).

6422293-1 | Inflammation, Organ Failure, Peritonitis
Adverse event was reported on Oct 19, 2009 by a Female patient taking Sulperazon (View Usage) (Dosage: 1.5 G, 3x/day) was diagnosed with acinetobacter infection and. Location: COLOMBIA , 40 years of age, Patient had the following side effects: inflammation, organ failure, peritonitis. During the same period patient was treated with PHENYTOIN (100 Mg, 3x/day) (View Phenytoin Review and Phenytoin Label ), VALPROIC ACID (250 Mg, 3x/day) (View Valproic Acid Review and Valproic Acid Label ), PARACETAMOL (1 G, 4x/day) (View Paracetamol Review and Paracetamol Label ), ENOXAPARIN SODIUM (60 Mg, 1x/day) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), RANITIDINE (50 Mg, 2x/day) (View Ranitidine Review and Ranitidine Label ).

6421476-4 | Chronic Obstructive Pulmonary Disease, Condition Aggravated
on Oct 21, 2009 Female patient from CHINA , 65 years of age, was diagnosed with lung infection and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: chronic obstructive pulmonary disease, condition aggravated. Sulperazon dosage: Unk. During the same period patient was treated with FORTUM (View Fortum Review and Fortum Label ).

6414215-4 | Platelet Count Decreased
on Oct 14, 2009 Female patient from JAPAN , 54 years of age, was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Sulperazon dosage: 1 G, 2x/day. During the same period patient was treated with ADALAT CC (Unk) (View Adalat Cc Review and Adalat Cc Label ), DILTIAZEM HYDROCHLORIDE (Unk) (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ).

6410194-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Pulmonary Oedema
Patient was taking Sulperazon (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, pulmonary oedema on Oct 12, 2009 from TURKEY Additional patient health information: Female patient , 64 years of age, was diagnosed with urosepsis and. Sulperazon dosage: 2 G, 2x/day. During the same period patient was treated with NAPROXEN SODIUM (Unk) (View Naproxen Sodium Review and Naproxen Sodium Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), RANITIDINE (Unk) (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.